Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

Roche schizophrenia drug fails

January 21, 2014 Research and Development, Sales and Marketing Roche, biopertin, schizophrenia

Roche’s investigational schizophrenia drug bitopertin has failed to help patients with the disorder’s negative symptoms when pitted against placebo. Two …
News

Novasep adds president to complete its executive team

January 21, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Nieuwenhove, Novasep

Thierry Van Nieuwenhove has joined contract manufacturing organisation Novasep as president of its Synthesis business unit. Educated as a bio-engineer, Van …
Appointment

Actavis makes Aurobindo sale

January 21, 2014 Sales and Marketing Actavis, Aurobindo, India, generics

Actavis is to sell its commercial operations in seven European countries to Aurobindo Pharma in a bid to put more …
News

Government sugar tsar works for Coca-Cola and Mars

January 20, 2014 Sales and Marketing UK government, action on sugar, macdonald

It has been revealed that the man tasked by the UK government to help implement tougher regulation on sugar levels …
News

J&J to sell division for $4.1 billion

January 20, 2014 Sales and Marketing Diagnostics, J&J, JJ, carlyle, ocd, ortho-clinical

Johnson & Johnson has been offered $4.15 billion by private equity firm The Carlyle Group to buy its Ortho-Clinical Diagnostics …
News

Shire sheds Dermagraft at $650m loss

January 20, 2014 Sales and Marketing Organogenesis, Shire, dermagraft

Shire has offloaded its Dermagraft business to Organogenesis just three years after purchasing the company. Given the sale has come …
News

Problems and solutions

January 20, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing adams, culture, pharma, problems, social media

Not long ago I was asked to be involved in a project that filmed UK-based pharma journalists in order to …
Feature

New chair for British Generic Manufacturers Association

January 20, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing bgma, thomas broeer

Thomas Broeer has been elected as chair of 





The British Generic Manufacturers Association (BGMA). Broeer, managing director of Kent Pharmaceuticals, …
Appointment

Europe nod for Gilead HCV pill

January 20, 2014 Sales and Marketing FDA, Gilead, HCV, hep C, sofosbuvir, sovaldi

Gilead Sciences’ once-daily, oral hepatitis C treatment Sovaldi has been given the green light by the European Commission, just a …
News

Google to use contact lens as diabetes monitor

January 17, 2014 Medical Communications, Sales and Marketing calico, contact, diabetes, google, lens

Google is developing a new type of contact lens designed to help patients with diabetes measure their blood sugar levels. …
News

Actavis: China is ‘too risky’

January 17, 2014 Sales and Marketing Actavis, China, bribery, generics, risky

The boss of generic drug manufacturer Actavis says his company is pulling out of China because the business environment there …
News

Gene trial ‘restores sight’

January 17, 2014 Research and Development, Sales and Marketing NHS, Oxford University Hospitals NHS Trust, choroideremia, eyes

A UK Phase I trial of a gene therapy designed to restore sight in patients suffering from an inherited form …
News

FDA issues online guidance

January 16, 2014 Manufacturing and Production, Medical Communications, Sales and Marketing FDA, Twitter, digital, online, ugc

The FDA has issued new guidance on what online promotional material pharma needs to show it. The document is out …
News

Reprieve for Merck’s vorapaxar

January 16, 2014 Sales and Marketing FDA, Merck, heart, vorapaxar

An FDA committee has voted that Merck’s troubled heart drug vorapaxar should be approved by the US regulator. The advisory …
News

Heptares appoints Tim Tasker as chief medical officer



January 16, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Heptares, tim tasker

Drug development firm Heptares Therapeutics has appointed Dr Tim Tasker as its chief medical officer (CMO) and VP of Development. …
Appointment
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026